ArticleJournal of translational medicine2025

Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma.

Jun-Peng Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.